The spinal implants and surgical devices market is primarily driven by the increasing burden of spinal disorders, rising demand for minimally-invasive surgeries, and technological advancements in bone grafting products. According to the National SCI Statistical Center 2018, the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the United States, or about 17,700 new SCI cases each year. Similarly, According to Spinal Injury Association UK 2019, about 2500 people are injured or diagnosed with spinal cord injuries every year and an estimated 50,000 people are living with spinal cord injuries in the UK.
Spine disorders (SD) and the associated pain are a major medical, social, and economic problem, due to its high prevalence and the ever-increasing number of patients in the general population. In most of the SD cases, patients experience the pseudo-radicular pain, and in the majority, the pain results from degenerative changes in the spine, involving the intervertebral discs, facet joints, and soft tissues. Spine-related disorders are among the most frequently encountered problems in clinical medicine.
The increasing incidence of spinal disorders, such as cervical spondylitis, prolapsed intervertebral disc, spinal stenosis, herniated disc, and vertebral fracture, helped in driving the spinal implants and surgery devices market, globally. Hence, the development of novel and effective technologies in spine care and devices is anticipated to drive the demand for these implants and devices.
Key Market Trends
The Spinal Non Fusion Devices Expected to Hold the Significant Market Growth
- The spinal non-fusion devices segment anticipated to exhibit a significant market growth during the forecast period, as a result of increasing incidences of spinal disorders, such as degenerative disc disease, among others.
- Degenerative disc disease begins with the changes in the intervertebral discs, but it also affects the other segments. According to the Arthritis Foundation, after the age of 40 are likely to suffer from disc degeneration diseases. The other factors include the acceptance of minimally invasive surgeries, such as disc arthroscopy and advantages over spinal fusion surgeries.
- According to the Scoliosis and Spinal Disorder, 2017, around 60% to 85% of the population experiences lower back pain. Non-fusion surgery can be used for the treatment of lumbar degenerative diseases. Hence, this factor is expected to fuel the spinal non-fusion devices market.
- Moreover, rising geriatric population that is more prone to arthritis and other spine related disorders expected to boost the overall market growth over the forecast period.
North America accounted for the Largest Share in the Global Market
North America spinal implants and surgical devices market holds significant share and is expected to show a similar trend over the forecast period. The growth in the United States is driven by technological advancement, elderly patients expecting a higher level of function, and reimbursement models that incentivize complex fusion surgery and have helped in driving the spinal implants and surgical devices market.
he interbody fusions were the most commonly performed spinal procedures in the United States. Another leading type of spinal fusion in the United States is a cervical fixation.
In 2017, Aesculab launched the lumbar artificial disc replacement, the activL Artificial Disc, which is now available at several hospitals. It is considered to be the next evolution of artificial discs, as it has an extra dimension of motion, which is not found in any other product in the market. With this latest generation disc available in the United States, spine surgeons believe they can cost-effectively provide artificial disc replacement to patients, making travelling overseas for surgery unnecessary.
On the other hand Asia Pacific projected to have notable growth rate owing to rising adoption of minimally invasive spinal procedures coupled with increasing burden of spinal cord injuries and disorders.
The market studied is moderately competitive, owing to the presence of a few major and small players in the market. The market players are focusing on technological advancements and reducing the cost of the products.
In October 2017, Teijin Nakashima Medical Co., Ltd., has acquired the orthopaedic business, principally spine fixation devices and spine cages of Century Medical, Inc. in Japan.
In July 2018, Medicrea, company pioneering the digital transformation of spinal surgery through A.I., predictive modelling and patient-specific implants entered a joint-venture agreement with National Surgical's spine division to launch an Australian subsidiary to introduce the Group’s products and patient-specific technologies in Australia and New Zealand.
In August 2019, Mantiz a South Korean specialist producer of spinal implants entered a partnership with Shining 3D Tech. Co. to use Shining 3D machines to produce medical implants.
Some of the major players in the market are Alphatec Spine Inc., Depuy Synthes (Johnson & Johnson), Globus Medical Inc., NuVasive Inc., Orthofix Holdings Inc., RTI Surgical Inc., Stryker Corporation, and Zimmer Biomet.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support